Today’s AI Top Pick: ALNY

8/10/2026 · Recently Alerted Turnaround screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Recently Alerted TurnaroundALNYBUY NOW9.0 / 108/10/2026

Alnylam is the cleanest 'oversold quality' setup in this pool. It checks every box the screen was designed to find: perfYear -49.62%, epsNextY +48.82%, salesYoY +95.14%, ROE 100.7, profitMargin 16.82%, PEG 0.29, recom 1.6, targetUpsidePct 72.9. Best-in-slate growth-at-a-reasonable-price fundamentals with a real earnings inflection thesis (fundamental_score 8). The tape confirms without asking you to chase. Position in 21-bar range is 0% (4h), 17.48% (1d), 12.4% (1wk) — you are buying near the floor, not the ceiling. Drawdowns of -33.5% / -23.7% / -31.7% show the pain is already priced. Yet Kronos forecasts are strongly positive across every horizon: 4h fc_short/mid/long +42.4/+64.3/+69.8, 1d +45.4/+69.5/+56.6, and even the weekly turns constructive (+1.5/+0.97/+7.15). That is the multi-timeframe agreement the brief asks for — no timeframe is signaling a fresh breakdown, unlike APP (1wk fc_long -66.67) or PSIX (1wk fc_long -48). bullish_prob=1, near_term_bullish=0.8. Today is the right entry because you are getting all three at once: (a) fundamentals that already qualify as a turnaround setup, (b) a max-pain price near the 21-bar low with RSI 34.2, and (c) forecast tape that projects a 45%+ mean-reversion move. Waiting for a bounce means paying up into strength when the whole edge is that the sellers have already puked. The Truist pessimistic note is the only real fly in the ointment, but consensus recom is still 1.6 and target upside remains ~73%. Vs the field: FICO has similar fundamentals but weaker weekly forecasts (fc_mid -3.97) and a live Q3 print to digest; CALX/TMUS have better multi-tf structure but weaker growth profiles; APP and TIGR have huge short/mid forecasts but weekly tape is deteriorating (APP 1wk fc_long -66.67, TIGR pos 100% on 4h — chasing). ALNY uniquely offers deep oversold + strong forecasts + elite fundamentals with no material negative catalyst.

Entry zone

$217–$223 (current $219.98, scale in on any dip toward $215 which is near the 21-bar 1d low)

Stop loss

$198 (below the recent 1wk swing low; ~10% risk, invalidates the mean-reversion thesis)

First target

$255–$265 (roughly the fc_short/mid 4h-1d projection of +20-25%, and prior consolidation resistance)

Longer target

$300–$320 (aligns with 1d fc_long +56.63% and analyst avg target implying ~73% upside from current)

Risks

Truist just issued a pessimistic forecast (Aug 4) — a follow-on downgrade cluster could pressure the tape
Implied volatility surging on options (Aug 6) suggests binary event risk; a data/clinical or guidance miss could gap it -15%
debtEq 2.21 is elevated for a biotech; any capital raise would be dilutive
1wk drawdown of -31.7% shows the primary trend is still down — the setup requires the weekly forecast (+7.15% long) to prove out; failure at $240 keeps it in the downtrend
Healthcare/biotech sector rotation risk — if broader tape sells off, high-beta biopharma leads down

Honorable mentions

FICOFundamental_score 8, recom 1.92, pos_in_range 0%/2.4% on 4h/1d (deeply oversold), forecasts +17/+34/+42 on daily. Slightly weaker weekly (fc_mid -3.97) and just reported Q3 so news risk is fresher, but the setup is nearly as clean as ALNY.

CALXBest multi-timeframe agreement in the pool — 4h/1d/1wk all forecast positive across all three horizons (up to +45% 4h long, +26.88% 1wk long). Recom 1.22 (strongest analyst support), fundamental_score 7.25, positive AI broadband headlines. Only knock: 4h pos 75% means it's already rallied intraday.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	ALNY	BUY NOW	9.0	Deep oversold (pos 0% 4h), elite fundamentals (PEG 0.29, salesYoY 95%), all-horizon positive forecasts (+45/+69/+57 on daily).
2	FICO	BUY NOW	8.5	Pos 0/2.4% at bottom of range with 1d forecasts +17/+34/+42; fundamental_score 8, PEG 0.68, profitMargin 34%.
3	CALX	BUY NOW	8.3	Cleanest multi-tf alignment: all 3 timeframes forecast up in every horizon; recom 1.22, PEG 0.46.
4	TMUS	BUY NOW	8.0	Four-tf agreement, low pos (11-40%), fwdPe 12.75, recom 1.42; steadier compounder than the biotech names.
5	BIRK	BUY NOW	7.7	All 4 tfs bullish, fundamental_score 7.5, PEG 0.86; only concern is 20% short float and board exit headline.
6	VST	BUY NOW	7.5	Low pos (3-9% on 4h/1d), PEG 0.16, ROE 43%; weekly long fc -36% is a caution flag.
7	MLCO	BUY NOW	7.3	1wk fc_long +59.96, PEG 0.35, fwdPe 8.1; pos 100% on 4h means chase risk near-term.
8	HNRG	BUY PULLBACK	7.0	Pos 0% at bottom, recom 1.0, targetUpside 98%; weekly forecasts deeply negative (-54% long) is a red flag.
9	APP	BUY PULLBACK	6.9	Huge short/mid forecasts (+46/+54) and -20% post-earnings gap creates value, but 1wk fc_long -66% signals structural risk.
10	TIGR	BUY PULLBACK	6.8	Massive forecasts (+76% 4h short), fwdPe 6.15; but pos 100% on 4h — wait for pullback to $4.50.
11	AMSC	BUY PULLBACK	6.5	Recom 1.0, targetUpside 89%; but 1wk fc_long -67% and only alt-energy narrative story.
12	MIR	BUY PULLBACK	6.3	4h/1d forecasts strong (+35-47), pos 0% 4h; PE 178 and 1wk fc negative caps conviction.
13	NRG	BUY PULLBACK	6.2	Pos ~10% on 4h/1d with fc +13-29% daily; -53% 1wk long fc and 'stock crashing' headline demand patience.
14	INTR	BUY PULLBACK	6.1	PEG 0.21, fwdPe 5.27, targetUpside 79%; near-term forecasts strong but weekly still bleeding.
15	KVYO	BUY PULLBACK	6.0	Citi raised PT to $36, fc_long +40% daily; PE 784 and negative operMargin keep this speculative.
16	PFSI	BUY PULLBACK	5.8	Multiple analyst PT cuts recent, but pos 17% and fc_mid +27% suggest bounce; recom 2.0 is the weakest here.
17	WING	BUY PULLBACK	5.7	Daily fc +48/+94/+91 is eye-popping and pos 2.6% at floor, but 1Y perf -64.68% shows structural break.
18	JBI	BUY PULLBACK	5.6	1wk fc +37/+89/+110; but earnings this week (Aug 11) is a coin flip.
19	ORCL	WAIT	5.5	Pos 99-100% across 1h/4h/1d + 4h/1wk forecasts negative — extended, wait for pullback despite $7B Pentagon win.
20	PSIX	WAIT	5.2	Pos 100% on 4h and 1d after 28% run; 1wk fc_long -48% — classic chase-and-fade setup.
21	KNF	WAIT	5.0	RSI 33, oversold post-earnings; but -12% gap down and PT cut, thesis needs time.
22	RBBN	WAIT	4.9	Recom 1.0 and 1wk fc_mid +47%, but salesYoY -7.62% and negative operMargin — turnaround unproven.
23	CELH	WAIT	4.8	Fc_mid +66% on daily but recent 'throw-away year' commentary and SKU rationalization = execution risk.
24	SPOT	WAIT	4.5	Insider selling ($10.6M) + 1wk fc_long -21.74% + targetUpside only 22.8% — no edge here.
25	NOW	WAIT	4.3	Pos 98-99% across 3 tfs after 25% weekly run; targetUpside only 12.5% — extended.
26	WEAV	WAIT	4.0	Near_term_bullish 0, negative operMargin -10.35 and profitMargin -10.05; no confirmation on tape.
27	SE	WAIT	3.8	Bullish_prob 0 and weekly pos 100% after +48% run; 4h/1d/1wk short-horizon forecasts negative — pure chase.
28	FUTU	AVOID	3.5	DOJ probe + class action + HK SFC asset freeze = live legal overhang trumps 1wk fc_long -35.66%.
29	SRAD	AVOID	3.2	UBS downgrade, cut 2026 outlook, -16.7% post-Q2; forecasts positive on short-tf but the narrative is broken.
30	SDA	AVOID	2.8	$87M micro-cap, PE 472, profitMargin 0.04%; 1wk fc_long +1142% is a data artifact, not a trade.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord